Parallel changes in bladder suburothelial vanilloid receptor TRPV1 and pan-neuronal marker PGP9.5 immunoreactivity in patients with neurogenic detrusor overactivity after intravesical resiniferatoxin treatment.
about
Capsaicin, Nociception and PainBotulinum toxin A for the Treatment of Overactive BladderResearch Findings on Overactive BladderNeural control of the lower urinary tractNeural mechanisms underlying lower urinary tract dysfunctionTRPA1 receptor modulation attenuates bladder overactivity induced by spinal cord injuryBladder sensory desensitization decreases urinary urgency.TRP channels in lower urinary tract dysfunction.Sodium channel Na v 1.7 immunoreactivity in painful human dental pulp and burning mouth syndrome.Expression and response of acid-sensing ion channels in urinary bladder to cyclophosphamide-induced cystitisChanges in afferent activity after spinal cord injury.PACAP/VIP and receptor characterization in micturition pathways in mice with overexpression of NGF in urothelium.Receptors, channels, and signalling in the urothelial sensory system in the bladderEffects of stimulation of muscarinic receptors on bladder afferent nerves in the in vitro bladder-pelvic afferent nerve preparation of the rat.Neurotrophin/receptor expression in urinary bladder of mice with overexpression of NGF in urotheliumIncreased expression of interleukin-6 family members and receptors in urinary bladder with cyclophosphamide-induced bladder inflammation in female rats.Mechanisms of disease: involvement of the urothelium in bladder dysfunction.Intravesical resiniferatoxin for the treatment of storage lower urinary tract symptoms in patients with either interstitial cystitis or detrusor overactivity: a meta-analysis.Acid-sensitive ion channels and receptorsMechanisms inducing autonomic dysreflexia during urinary bladder distention in rats with spinal cord injury.Integrated control of lower urinary tract--clinical perspectiveIncreased levels of SV2A botulinum neurotoxin receptor in clinical sensory disorders and functional effects of botulinum toxins A and E in cultured human sensory neurons.Changes in the muscarinic receptors on the colonic smooth muscles of rats with spinal cord injury.Afferent nerve regulation of bladder function in health and disease.Alteration in TRPV1 and Muscarinic (M3) receptor expression and function in idiopathic overactive bladder urothelial cells.Therapy Insight: bladder dysfunction associated with multiple sclerosis.Neuromodulatory therapies in female pelvic medicine and reconstructive surgery: biological agents.Current and emerging investigational medical therapies for the treatment of overactive bladder.Plasticity in reflex pathways to the lower urinary tract following spinal cord injuryThe challenge of overactive bladder therapy: alternative to antimuscarinic agents.TRPs in bladder diseasesUpregulation of vascular endothelial growth factor isoform VEGF-164 and receptors (VEGFR-2, Npn-1, and Npn-2) in rats with cyclophosphamide-induced cystitis.The pharmacological challenge to tame the transient receptor potential vanilloid-1 (TRPV1) nocisensorBladder dysfunction in multiple sclerosis.Bladder afferent signaling: recent findings.Is the urothelium intelligent?TRP family proteins in the lower urinary tract: translating basic science into new clinical prospective.From urgency to frequency: facts and controversies of TRPs in the lower urinary tract.Botulinum toxin injection for lower urinary tract dysfunction.Transient receptor potential channels in bladder function.
P2860
Q26744369-9B40AC55-ABAE-49E8-9AD2-412E805631FAQ26764765-A62319D5-CF98-40F5-A23B-3D929981B1D4Q26801459-956AF2FF-2F14-4C64-BB73-A22891F08F5BQ26828785-52788D35-68F4-46E5-9935-03B25356E46CQ26852088-FF67E794-468A-4345-91EF-13F576995BDEQ28564612-F3214282-C3D0-4CEB-A3F9-13B4FA130D33Q30832054-5B6A5DD7-91B5-42A6-8AD6-25D2600396A4Q33562153-7B073EFF-A8B9-4701-A20E-116248602DAFQ33596969-8B3DB0E1-0B65-4787-91C5-C0B745B25954Q33840581-B2513B8E-F51C-417C-BCAB-01AD03B55916Q33936100-F9C93EE9-5FE0-4760-A1F4-379B985D07E1Q34204160-71150B3F-E486-42B0-AD6A-14CE57EEBB0FQ34516186-F8101DBC-103F-4F4D-B6FF-9217D83A432AQ34554749-AB46DE05-7868-47C2-872F-FEC4155F8B43Q34599842-A0BA572B-963F-469C-BD37-BC56FB521F12Q34603839-EF9EB30D-57A1-448B-B0FF-4C9D5FDCC51BQ35057494-589B5EF9-E4C6-4AE5-9C87-345F093180AEQ35077636-8FAD0433-AF14-4F5B-BE8C-1522037D6CF4Q35178189-13BA3DBA-7E18-40D9-92F6-9054F231E9CCQ35532931-729F6017-EE30-42B2-ADC9-CF116E4DE11AQ35545736-AD959643-2086-405E-8C72-66DA9E3B7F61Q35548169-9AFCD0B0-CAEA-43D8-B4FA-43C73CE661F9Q35843425-18445014-C66E-4B6F-9B39-FBB4F2188647Q36057867-C46EE537-24D2-4553-A31C-1BE1C089D4CFQ36388886-6447212B-CAD7-4F80-B388-2CDFD29554C6Q36395096-8E851306-F705-4815-8283-A920ADB13A30Q36566845-12834CCE-2DE4-48CC-A868-83535E57760AQ36568728-51B00604-442D-4877-BE48-1280828A6ACBQ36634346-A0A0DB47-A8EA-480A-ACC4-30FE0DE4F36BQ36698662-9AC9C1D2-D99E-4771-A1F0-0CE853DFD2EEQ36845497-2DA011C2-C7C6-4E6A-8303-94A1665384B5Q36877837-29464A6A-FFD5-49EC-B3B7-0BF921371C62Q37023861-D7AD9FA9-6B83-4513-8974-8FA0FE680815Q37409485-A3667B28-651C-4CD7-9A50-6C3BED613830Q37695617-598F7F1A-9F70-4B5D-AAEA-5AF59E852E02Q37739959-9ECF3720-74A5-407B-BE00-0C0995487915Q37905551-B89508B4-DAE5-4C7B-B8C8-3CAF683CBA6AQ37942411-293D6569-8425-4038-925F-875C11DBC077Q38008697-D6F99650-3F06-4456-AAE2-00284681DA05Q38056773-9F1A13D5-282A-47CC-A78B-D0CE545FBE99
P2860
Parallel changes in bladder suburothelial vanilloid receptor TRPV1 and pan-neuronal marker PGP9.5 immunoreactivity in patients with neurogenic detrusor overactivity after intravesical resiniferatoxin treatment.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Parallel changes in bladder su ...... cal resiniferatoxin treatment.
@en
Parallel changes in bladder su ...... cal resiniferatoxin treatment.
@nl
type
label
Parallel changes in bladder su ...... cal resiniferatoxin treatment.
@en
Parallel changes in bladder su ...... cal resiniferatoxin treatment.
@nl
prefLabel
Parallel changes in bladder su ...... cal resiniferatoxin treatment.
@en
Parallel changes in bladder su ...... cal resiniferatoxin treatment.
@nl
P2093
P1433
P1476
Parallel changes in bladder su ...... cal resiniferatoxin treatment.
@en
P2093
A N Apostolidis
C J Fowler
F Scaravilli
T S Jacques
P304
P356
10.1111/J.1464-410X.2003.04722.X
P577
2004-04-01T00:00:00Z